Aclaris Therapeutics

ACRSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$825.412 M

$5.91 -2.96%

Close of 7 Aug 2026

Revenue

$7.83M

#3216 by revenue

Earnings

-$64.9M

Loss-making

Shares outstanding

147,198,893

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#173Theravance BiopharmaTBPH$872.8M
#174Kura OncologyKURA$849.6M
#175Aclaris TherapeuticsACRS$825.4M
#176Climb BioCLYM$801.7M
#177Monopar TherapeuticsMNPR$798.6M

Where these numbers come from

Share counts and financials for Aclaris Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.